Ultragenyx Pharmaceutical | RARE - Laba Sebelum Pajak





Laba Sebelum Pajak Perubahan Tanggal
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Esperion Therapeutics USD 63.67M 95M 2025-12
Immunic USD -19.3M 6.28M 2025-12
Insmed USD -326.93M 41.77M 2025-12
Ionis Pharmaceuticals USD -93M 135M 2026-03
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Kyowa Hakko Kirin JPY 39.3B 13.35B 2025-12
MacroGenics USD -14.93M 31.75M 2025-12
Moderna USD -187M 631M 2025-09
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09
Xoma USD 15.98M 24.58M 2024-06